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Objective To evaluate the incidence of urinary tract 
infections (UTIs) after transurethral laser therapy of 
the prostate and the need for peri-operative antibiotics.
Patients and methods One-hundred and sixteen patients 
(mean age 65 years, range 51-85) with benign
were with a
the TULIP device,
prostatic enlargement 
Nd:YAG laser, using 
Urolase fibre or the Ultraline fibre. The incidence of 
voiding complaints, UTIs and the need for catheteriz­
ation after treatment were assessed. The first 43 
patients (Group I) received no antibiotics peri- 
operatively and the next 73 patients (Group II) 
received co-trimoxazole for 5 days.
Results The patients treated using the TULIP device had 
more urinary complaints after treatment than those 
treated using the Ultraline and Urolase fibres. In Group 
I, 48% of the patients developed a UTI and in Group 
II the incidence of UTIs decreased to 30% after treat­
ment. The incidence of UTIs was unrelated to the 
procedure performed. Although not statistically sig­
nificant, peri-operative antibiotics te 
incidence of UTIs. Prolonged catheterization was corre­
lated with the incidence of UTI. In Group I, patients 
who were treated using the Ultraline procedure had 
their catheter removed after a mean of 24 days, 
compared with 21 days for those treated with the 
Urolase and 19 days with the TULIP device. In Group 
II, the patients needed catheterization for a mean of 
17 days following Ultraline treatment and 16 days 
following the Urolase procedure.
Conclusions Antibiotic prophylaxis tended to decrease 
the incidence of post-treatment UTIs. However, there 
was no clear association between the presentation and 
duration of complaints and the presence of UTIs.
Keywords Prostate, laser treatment, urinary tract 
infections, catheterization
Introduction
Urinary tract infection (UTI) and septicaemia are import­
ant sequelae of transurethral surgery. Significant contro­
versy surrounds the use of prophylactic antibiotics in
low power, deep coagulation of the prostate can be 
achieved, whilst at high power direct tissue vaporization 
occurs. With our increasing experience of laser treat­
ment, some patients apparently required prolonged per­
iods of catheter drainage after treatment. Moreover, UTIs
prostatic surgery. Septicaemia occurs in only 0-4% of and epididymitis seemed to occur more frequently than
patients undergoing transurethral resection of the pros­
tate (TURP) [1J. Studies on the role of antibiotic prophy-
in patients treated by TURP.
The aim of this study was to evaluate the incidence
laxis have focused on the incidence of UTI and some of UTIs after transurethral laser therapy of the prostate
have shown that antibiotic prophylaxis decreased the 
incidence of UTIs [2-5] whereas others reported no 
decrease [6-9]. In these studies IJTIs occurred in 5-10%  
of patients even when antibiotics were used prophylac- 
tically. In a review, Chodalc and Plan I, concluded that 
no recommendations could be made regarding the use 
of prophylactic antibiotics [10],
Over the last 3 years transurethral laser therapy has
and the need for peri-operative antibiotics. Furthermore, 
we examined whether there was a correlation between 
the presentation of UTIs, the duration of 
and the complaints observed.
Patients and methods
Only those patients with sterile urine and
been suggested as a new treatment modality for benign transurethral laser prostatectomy were included in the
prostatic enlargement (BPE) [11-14]. Several devices 
have been developed and evaluated, amongst which the
study. Any patient with a UTI, urinary retention with 
an indwelling catheter or recent use of antibiotics within
side-firing laser fibres are currently the most popular. At the 7 days preceding the operation were excluded. All 
--------------------------------------------------------------------------- pre-operative urine cultures were obtained by the mid-
Aecepted for publication 15 August 1995 stream clean-catch method.
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treatment, the genitalia were cleaned with oped a symptomatic UTI or urine
povidone-iodine solution and sterile water was used as culture was considered to be infected when there were
the irrigation fluid. A suprapubic 16 Ch Foley catheter 1 0 5 o r g a n ism s/m L
was inserted and the laser treatment performed using scored for their presence and duration, and scoring
one of three techniques. With the TULIP device laser began on the day of discharge and continued until the
energy was applied, under ultrasonographic guidance, patient was free of complaints.
to the prostate, drawing lines from the bladder neck to Although the study was not randomized, a statistical
the verumontanum and causing deep coagulation. The analysis could be performed because the same inclusion
first 11 consecutive patients were treated with this criteria were used for both groups. The 11 patients
device. After this study, a randomized study was per- treated with the TULIP device were all in Group I 
formed, using two side-iiring laser fibres under direct omitted
vision. The Urolase fibre also achieves deep coagulation joint logistic regression ant
by at pre-determined areas of the LOGISTIC) w as applied to
presence or e of a UTI andprostate (2, 5, 7 and 10 o ’clock positions). The Ultraline between the 
libre enables vaporization of prostate tissue and treat- antibiotic prophylaxis, type of laser and the duration of 
ment was performed by ‘painting’ the prostate. These catheterization.
have been described in detail elsewhere
The patients were discharged 1 day after treatment Results
with the suprapubic catheter blocked. The patients were After treatment, 21 patients (48%) in Group I and 22 
allowed to urinate spontaneously and the suprapubic patients (30%)  in Group II developed a documented UTI. 
catheter was removed when the patients were able to In Group I, eight (62%) patients treated with the
urinate adequately with a low post-voiding volume. Ultraline, nine (47%) with the Urolase and four (36%)
The first 43 patients (mean age 65 years, range with the TULIP procedure developed UTIs. In Group II,
51-85), including those treated with the TULIP device, the incidence was 35% (11/31) in the Ultraline and
received no antibiotics peri-operatively (Group I) while 26% (11/42) in the Urolase group. The mean duration
the 73 patients (mean age 65 years, range 50 -79  years) to catheter removal was 21 days (range 2-72) in Group
treated consecutively received co-trimoxazol peri- I and 16 days (range 3 -58) in Group II; with laser type, 
operatively for 5 days (Group II). In Group I, 13 patients in Group I the mean durations were 24 days (Ultraline), 
were treated with the Ultraline fibre, 19 with the Urolase 21 days (Urolase) and 19 days (TULIP). In Group II, the 
fibre and 11 with the TULIP device; in Group II, 31 were mean duration of catheterization was 17 days lor the
ind 42 with the Urolase Ultraline and 16 days for the Urolase group. For Group
I, in the group of patients with a positive urine culture, 
the catheter w as removed after a mean of 24 days, while
fibre.
Urine cultures were taken during the follow-up at 2
and 4 weeks and after removal of the catheter, Every in the remaining patients the catheter was removed after
was when the was identified.
were also given when the patient developed
19 days; the results were similar for Group II (Table 1). 
To investigate the influence of antibiotics, laser type
a >  58 C, became clinically bacteraemic or devel- and duration of catheterization on the probability of
Table 1 The average duration of catheterization, the type of procedure performed and the results of post-operative urine cultures in 
patients with ((»roup ID and with no peri-operative antibiotics (Group I)
m
Procedura
Positive culture
Duration of catheterization (dai/s) (number of patients)
Negative cultun Ul
H M n tn ta M M iia o iM t M'lUJJIfcH'U
Croup I
llltraline 23 (8) 25 (5) 24 (13)
Urolase 28 (9) 15 (10) 21 (19)
TULIP 1 5 (4) 21 (7) 19 (11)
Total 24 (21) 19 (22) 21 (43)
Croup II
llltraline 22 (11) 14 (20) 17 (31)
Urolase 19 (11) 15 (31) 16(42)
Total 21 (22) 15 (51) 16 (73)
■BOI
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developing a UTI a logistic regression was performed. 
According to the likelihood-ratio test, 
regression variables combined were significant (P
(12%) in Group I 
seven patients (10%) in Group II.
itis compared with
0 .0 1 ). the Wald test For each variable, there was Discussion
no significant relation with laser type (P=0.29), but the
probability of developing a UTI was significantly higher Transurethral resection of the prostate is the most
(P=0.03) with a longer duration of catheterization and common operation for bladder outlet obstruction and is
although not significant (P = 0.07) there tended to be /a one of the most frequently performed operations in men
lower probability of developing a UTI with the use of 65 years or older [15]. Amongst other new, less invasive
antibiotics. Patients with a UTI had complaints lor a 
mean of 45 days (range 6-149) and similarly, for 
patients with no UTI, the mean was 45 days (range 
0-95) (Table 2). There was no clear relationship between
treatments for BPE, transurethral laser treatment of the 
prostate has become available recently. The first report 
on the use of lasers to treat BPE were presented by 
Costello et al [16]. In two recent papers reporting laser
the duration of the complaints, the type of complaints ablation of the prostate with different techniques [11,17] 
and the presence of UTIs. Table 3 shows the results of it was concluded that the outcome of treatment was 
urine culture and the organisms cultured. Five patients excellent and that the morbidity after treatment was
minor. However, the majority of patients had voiding
Table 2 Post-operative complaints and the presence of urinary 
tract infection in patients with (Group II) and with no (Group 1) 
peri-operative antibiotics
Urinary tract infection
Group I Yes No Total
Number of patients 21 22 43
Complaints number [%]
Frequency 15 (71) 12 (55) 27 (64)
Dysuria 16 (76) 12 (55) 28 (65)
Haematuria 16 (76) 12 (55) 28 (65)
Pain 7 (33) 5 (23) 12 (28)
Group 11 Yes No Total
Number of patients 22 51 73
Complaints (number [%])
Frequency 12 (55) 23 (45) 35 (48)
Dysuria 10 (46) 22 (43) 32 (44)
Haematuria 16 (73) 36 (71) 52 (71)
Pain 8 (36) 11 (22) 19 (26)
Table 3 Results of urine cultures
Bacteria Group 1 Group 11
Hscherichia coli 4 3
Klebsiella pnei nn oniae 4 0
Staphylococcus aureus 4 i
Hnterococcns faecalis 3 5
Acinelobacter bawmnnii 2 1
Proteus mirabtlis
/ IjaÍi/I/í/ áí\m /l*/>1 I l'l/'íí Í
2
1
0
1t í li  ö / m i r /  Jt í lUlull
Enterobacter spp
i
1
1
0
Klebsiella oxytoca 1 1
Pseudomonas spp 1 3
Coagulase -ve Staphylococcus 0 1
Staphylococcus epidermidis 1 5
complaints, possibly due to UTIs. On the other hand, a 
difference in the severity of complaints was noted when 
different techniques were used. It was thought that these 
differences might not be related to the presence of an 
infection.
No standard exists in the urological community 
regarding the use of prophylactic antibiotics for TURP. 
The reported incidence of UTI in patients undergoing 
TURP ranges from 2.3 [18] to 42% [19]. In several 
studies [5,20,21] prophylactic antibiotics were rec­
ommended and Childs [22] stated that TURP should be 
classified as a contaminated procedure, with a 20% risk 
of infection, and also recommended prophylaxis. To 
define the prevalence of prostatic bacterial infection, 
Gorelick et al conducted a study in which tissue from 
patients undergoing prostatectomy was submitted for 
quantitative bacterial tissue culture [23]. These data 
showed a significant prevalence (21%) of prostatic infec­
tion in patients undergoing prostatic surgery.
In patients with a sterile pre-operative urine culture, 
no peri-operative antibiotics are administered for TURP 
in our department. When transurethral laser therapy 
became available, it was also decided that peri-operative 
antibiotics would not be used in these patients. However, 
during follow-up many patients had irritative complaints 
for several days to weeks after treatment and the inci­
dence of UTIs seemed high.
In the present study, evaluation of the patients treated 
without peri-operative antibiotics showed that 48% of 
them developed a UTI. Indeed, compared with the inci­
dence seen after TURP (mean 10-20%), this percentage 
is high. Three factors were evaluated to explain this high 
incidence; the presence of necrotic tissue after the pro­
cedure, the presence of an 
prolonged catheterization. Moreover, relationships 
between the complaints and the presence of a UTI were 
examined.
© 1996 British Journal of Urology 77, 228-2 52
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The incidence of UTI was highest in the Ultraline- 
treated group, followed by the Urolase and the TULIP 
groups. However, adjusted for the use of prophylactic
antibiotics and the duration of ce ization,
were no significant differences between those treated 
with the Ultraline and Urolase fibres. The discrepancy in 
the incidence of UTIs for the three procedures was not 
related to the type of laser fibre but to the duration of 
catheterization. All three techniques create extensive 
necrotic tissue, caused by coagulation. Thus the prostate 
turns into an ideal culture medium for bacteria, which 
may already be present in the prostate, as 
by Gorelick cl al. [23].
The presence of an indwelling ce 
the incidence of UTIs. In those patients treated
mean time to 
removal was 21 days. In cases of infection, the catheter 
was removed at a mean of 24 days while in the 
remaining patients the catheter was removed a mean 
of 5 days earlier. Patients with a prolonged indwelling 
catheter are susceptible to infection with mixed cultures 
of organisms [4,24]. In the 73 patients receiving 
prophylactic antibiotics a similar trend occurred; the 
mean duration of catheterization was 16 days, but was 
21 days in infected and 15 days in the uninfected 
patients.
From the logistic regression analysis, it is concluded 
that this higher incidence of UTIs may be explained 
partly by a longer duration of ciitheterization. Recently, 
Costa presented results of a randomized study to evaluate
Antibacterial prophylaxis is useful in 
ablation of the prostate [25]. In agreement with the
50% of the patients in a group receiving 
developed bacteriuria. In patients receiv- 
dose regimen of a difluoroquinolone, bacteri-
in only 10%, whereas 5% of those 
receiving a multi-dose regimen developed bacteriuria 
during follow-up. In contrast, to the present study, the 
median duration of catheterization was only 2 -3  days;
no pr
ing a s
uria
am •e in On the
other hand, infections may impair wound healing in the 
prostatic fossa and thus result in a need for prolonged
operative a n tibio tics
of IJTIs t  'c treatment,
incidence of UTIs remained at 30%.
1m nn vc significant
not be
as a
occurred in patients in both Group I and II. 
the incidence of epididymitis after TIJRP s 
underestimated. Epididymitis has been 
complication of prostatic surgery for many years, 
urologists believe that the route of infection is 
the lumen of the vas, and the incidence of
at 5-10% [26]. Possibly, urethral cath­
eterization has only an indirect effect, on
of by urinary
Because of the morbidity caused by epididymitis, any 
means which decreases the incidence of epididymitis 
should be employed.
In the present study there was no evident; relation 
between the presence or duration of complaints after 
laser treatment and the incidence of UTIs (Table 2). 
Therefore, one cannot rely on the complaints presented 
by these patients to determine whether a UTI is present 
and causing the complaints. However, the duration of 
complaints and the type of procedure performed were 
associated. In an earlier phase, it was
and perineal 
nounced in the TULIP group than in 
[111 and
were more' pro-
ence may be explained by the 
different procedure performed. During the insertion of the 
TULIP device, more tissue trauma may be caused than 
with other techniques. Moreover, 
requires a 48 F balloon to be filled with 0.1 -0 .2  MPa
|T||R
of pressure, which may cause a commisurotomy and 
stretching of the capsule of the prostate. Finally, patients 
treated with the Ultraline procedure im y have more 
complaints than those treated with the Urolase because 
a larger area of the prostate surface is treated, sometimes 
very close to the bladder neck. Compared to the TULIP 
group, the patients treated with the Ultraline fibre had 
fewer complaints.
The high incidence of UTIs after laser prostatectomy 
may have many causes. There was a poor relationship 
between complaints and the presence of UTIs. There is 
a paucity of reliable indicators to identify pre-operatively 
patients that will develop complaints post-operatively, or 
will have a UTI. The major cause seems to be prolonged 
catheterization, but currently it is i to predict
which patients will develop an infection. Peri-operative 
antibiotics tended to reduce post-laser UTIs, 
was no relation with the type of procedure performed.
:ause few patients were treated within each
group, conclusions cannot be made. 
of the high rate of infection fi m
rt the
of patients with peri-operative antibiotics, 
we have decided to proceed with laser therapy 
prophylactic i
daily for 5 days). When considering the routine use of
disadvantages must be con- 
, including added costs, selection of resistant 
organisms and allergic reactions, If antibiotics are admin­
istered, for how long should they be continued and 
which antibiotic drug should be chosen? These questions 
need to be answered in a randomized (placebo) controlled
Furthermore, laser of
should be modified so that the need for
2 3 2  E. TE SLA A et a l
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